Comparison
Omega-3 (DHA/EPA) vs Alpha-Lipoic Acid
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Alpha-Lipoic Acid
Universal antioxidant active in both lipid and aqueous environments. Supports mitochondrial function and AGE reduction.
| Field | Omega-3 (DHA/EPA) | Alpha-Lipoic Acid |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 300–600mg |
| Half-life | 24h | 1h |
| Onset | – | – |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 1900 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Alpha-Lipoic Acid are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Alpha-Lipoic Acid Universal antioxidant active in both lipid and aqueous environments.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) matches the evidence base of Alpha-Lipoic Acid (evidence A, safety 4/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Alpha-Lipoic Acid if
Alpha-Lipoic Acid is the better fit when your goal aligns with its mechanism (A 'universal' antioxidant, uniquely active in both lipid (cell membrane) and aqueous (cytoplasm) environments because of its dithiol functional group) and the dose range (300–600mg) suits your protocol. Half-life is 1h.